These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2718239)

  • 1. Prevention of transmission of human T-cell lymphotropic virus type-I by blood transfusion by screening of donors.
    Nishimura Y; Yamaguchi K; Kiyokawa T; Takatsuki K; Imamura Y; Fujiwara H
    Transfusion; 1989 May; 29(4):372. PubMed ID: 2718239
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
    Inaba S; Sato H; Okochi K; Fukada K; Takakura F; Tokunaga K; Kiyokawa H; Maeda Y
    Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques.
    Balkhy HH; Memish ZA; Abed E; Qasem L; Amer AB; Masoud S; Hajeer AH
    Mil Med; 2004 Mar; 169(3):251-3. PubMed ID: 15080248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I--a screen too many?
    Lancet; 1990 Nov; 336(8724):1161. PubMed ID: 1978032
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion transmission of human T-lymphotropic virus types I and II: lessons to be learned from look-back investigations and implications for patient counseling.
    Levine PH; Manns A
    Transfusion; 1993 Jan; 33(1):4-6. PubMed ID: 8379967
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
    Sobata R; Matsumoto C; Uchida S; Suzuki Y; Satake M; Tadokoro K
    Vox Sang; 2015 Aug; 109(2):122-8. PubMed ID: 25930000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-lymphotropic virus and transfusion safety: does one size fit all?
    Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G
    Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
    Donegan E; Lee H; Operskalski EA; Shaw GM; Kleinman SH; Busch MP; Stevens CE; Schiff ER; Nowicki MJ; Hollingsworth CG
    Transfusion; 1994 Jun; 34(6):478-83. PubMed ID: 8023388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood safety strategies for human T-cell lymphotropic virus in Europe.
    Laperche S; Worms B; Pillonel J; ;
    Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of transfusion-transmitted human T-cell lymphotropic virus-type I in Latin America.
    Gotuzzo E
    Int J Infect Dis; 2000; 4(2):59-61. PubMed ID: 10737839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
    Murphy EL
    Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection.
    Inaba S; Okochi K; Sato H; Fukada K; Kinukawa N; Nakata H; Kinjyo K; Fujii F; Maeda Y
    Transfusion; 1999 Oct; 39(10):1104-10. PubMed ID: 10532605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion].
    Lefrère JJ
    Presse Med; 2000 Jun; 29(20):1134-8. PubMed ID: 10901796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection.
    Vermeulen M; van den Berg K; Sykes W; Reddy R; Ingram C; Poole C; Custer B
    Vox Sang; 2019 Jul; 114(5):467-477. PubMed ID: 31131453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-lymphotropic virus infection: is it a threat?
    Zaaijer H
    Transplant Proc; 1996 Oct; 28(5):2940. PubMed ID: 8908133
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion transmission of human T-lymphotropic virus type I (HTLV-I) from an asymptomatic blood donor: conservation of LTR U3, env, and tax nucleotide sequences in a recipient with HTLV-I-associated myelopathy.
    Gasmi M; D'Incan M; Desgranges C
    Transfusion; 1997 Jan; 37(1):60-4. PubMed ID: 9024491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands.
    Prinsze FJ; Zaaijer HL
    Vox Sang; 2012 Apr; 102(3):198-203. PubMed ID: 21895678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations.
    Kleinman S; Swanson P; Allain JP; Lee H
    Transfusion; 1993 Jan; 33(1):14-8. PubMed ID: 8424263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
    Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
    Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.